Atlas Trials

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Clinical trial NCT00916058 · COMPLETED

Trial details

NCT number
NCT00916058
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2009-04-23
Primary completion
2016-03-11
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.